| Literature DB >> 26246089 |
Xianli Lv1, Peng Liu1, Youxiang Li2.
Abstract
Cerebral arteriovenous malformation (AVM) in pregnancy is a complex situation and there is no agreement on its hemorrhage risk and treatment. Although studies on bleeding risk of cerebral AVMs in pregnancy are very few, and they provide different results, pregnancy will increase the hemorrhagic risk of AVM and ruptured cerebral AVM in pregnancy should be actively treated. After intracranial hemorrhage, cerebral angiography should be performed for pregnant women shielded correctly. Cerebral angiography could clearly demonstrate the characteristics of cerebral AVM. Results from the literature show that the radiation dose of endovascular and stereotactic radiotherapy for cerebral AVM in pregnancy was below the safety value and was safe. For an unruptured AVM in pregnancy, if there are no bleeding factors, e.g. no coexisting aneurysm, smooth venous drainage, no venous ectasia, or high risk of treatment, then it should be observed conservatively.Entities:
Keywords: cerebral arteriovenous malformation; pregnancy; treatment
Mesh:
Year: 2015 PMID: 26246089 PMCID: PMC4757278 DOI: 10.1177/1971400915589692
Source DB: PubMed Journal: Neuroradiol J ISSN: 1971-4009